| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0735-1097(95)00433-5 |
| P698 | PubMed publication ID | 8522689 |
| P2093 | author name string | May A | |
| Schömig A | |||
| Neumann FJ | |||
| Ott I | |||
| Gawaz M | |||
| Mössmer G | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | 15-21 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting | |
| P478 | volume | 27 |
| Q28191519 | A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial |
| Q77700125 | Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes |
| Q24793199 | Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention |
| Q73407496 | Antiplatelet effect of ticlopidine after coronary stenting |
| Q41343897 | Antiplatelet therapy following stent deployment. |
| Q64957750 | Antiplatelet therapy for tibial balloon angioplasty: A clinical perspective. |
| Q33805244 | Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents |
| Q41343882 | Antithrombotic therapy with intracoronary stenting. |
| Q73716490 | Clinical and angiographic outcome after angiography-guided stent placement in small coronary vessels |
| Q61439470 | Continued expansion of the nitinol self-expanding coronary stent: Angiographic analysis and 1-year clinical follow-up |
| Q45995580 | Coronary artery disease: Platelet activity: an obstacle for successful PCI. |
| Q73964100 | Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patients |
| Q33795842 | Coronary artery stents: appropriate use of adjunctive pharmacotherapy to prevent stent thrombosis |
| Q77225754 | Diagnosing coronary arterial stent thrombosis and arterial closure |
| Q28176313 | Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation |
| Q37599605 | Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register |
| Q35208684 | Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE). |
| Q38131848 | Genetics of platelet inhibitor treatment |
| Q37781241 | ISAR - A Story of Trials With Impact on Practice - |
| Q37498604 | Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel |
| Q77408079 | Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model |
| Q77225765 | Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries |
| Q24792495 | Long-term outcome after coronary stenting |
| Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
| Q73848594 | Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography |
| Q74012794 | PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement |
| Q47887100 | Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis |
| Q78192649 | Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome |
| Q40890618 | Prognostic significance of spontaneous echo contrast in the thoracic aorta: relation with accelerated clinical progression of coronary artery disease. |
| Q34232458 | Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass |
| Q37164383 | The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention |
| Q30426519 | Ticlopidine and aspirin interactions |
| Q85650904 | [Clinical pharmacology of current antiplatelet drugs] |
| Q56944503 | abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile |
Search more.